Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Frederic Colombel

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Gastroenterology|May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's DiseaseArthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert ConsensusSerre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, et al.
Journal of Crohn'S & Colitis|September 28, 2023
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis SubtypesTenghao Zheng, Giulia Roda, Yamile Zabana, et al.
Gastroenterology|June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's DiseaseParambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative ColitisParambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Gastroenterology|September 27, 2020
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related DiseaseMayte Suárez-Fariñas, Minami Tokuyama, Gabrielle Wei, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
Science Immunology|April 19, 2024
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
The American Journal of Gastroenterology|October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS ConsortiumAmanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Gastroenterology|May 27, 2022
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's DiseaseArthur Mortha, Romain Remark, Diane Marie Del Valle, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2024
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert ConsensusSerre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, et al.
Journal of Crohn'S & Colitis|September 28, 2023
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis SubtypesTenghao Zheng, Giulia Roda, Yamile Zabana, et al.
Gastroenterology|June 2, 2018
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn's DiseaseParambir S Dulai, Brigid S Boland, Siddharth Singh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2020
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative ColitisParambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Gastroenterology|September 27, 2020
Intestinal Inflammation Modulates the Expression of ACE2 and TMPRSS2 and Potentially Overlaps With the Pathogenesis of SARS-CoV-2-related DiseaseMayte Suárez-Fariñas, Minami Tokuyama, Gabrielle Wei, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
Science Immunology|April 19, 2024
Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitisPablo Canales-Herrerias, Mathieu Uzzan, Akihiro Seki, et al.
The American Journal of Gastroenterology|October 3, 2022
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS ConsortiumAmanda M Johnson, Maria Barsky, Waseem Ahmed, et al.
Pageof 38